This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Alliance, Lexon, others win UK court appeal against nausea-drug 'pay for delay' fines

By Simon Zekaria ( May 23, 2024, 16:34 GMT | Insight) -- Alliance Pharmaceuticals and other drug companies have seen a collective UK antitrust fine of more than 35 million pounds over alleged anticompetitive behavior in the supply of nausea drug prochlorperazine quashed on appeal by competition judges. The Competition Appeal Tribunal also reversed disqualifications of several directors over the alleged conduct.Alliance Pharmaceuticals and other drug companies have seen a collective UK antitrust fine of more than 35 million pounds ($44 million) over alleged anticompetitive behavior in the supply of nausea drug prochlorperazine quashed on appeal by competition judges....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections